TRACON Pharmaceuticals (TCON) News Today → Urgent Nvidia Warning (From Altimetry) (Ad) Free TCON Stock Alerts $1.81 +0.10 (+5.85%) (As of 05/2/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTRACON Pharmaceuticals Incmoney.usnews.com - April 26 at 7:25 AMTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Sees Significant Drop in Short Interestmarketbeat.com - April 11 at 8:03 AMBuy Rating Reaffirmed for TRACON Pharmaceuticals Post-Reverse Split and Envafolimab Valuation Updatemarkets.businessinsider.com - April 10 at 7:42 PMTRACON announces 1-for-20 reverse stock splituk.investing.com - April 10 at 9:41 AMWall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024investorplace.com - April 10 at 6:30 AMmarketbeat.com - April 10 at 6:04 AMShares of Tracon Pharmaceuticals Tumble 22% on Reverse Splitmarketwatch.com - April 8 at 6:03 PMTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Reverse Stock Splitfinanznachrichten.de - April 8 at 1:03 PMTRACON Pharmaceuticals Announces Reverse Stock Splitglobenewswire.com - April 8 at 9:10 AMBuy Rating Affirmed for TRACON Pharmaceuticals Amid Promising Envafolimab Trial Outlookmarkets.businessinsider.com - April 4 at 2:31 AMTracon Pharma drops after pivotal data for cancer drugmsn.com - April 3 at 4:29 PMTRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Plannedfinance.yahoo.com - April 3 at 8:38 AMJonesTrading Reaffirms Their Hold Rating on TRACON Pharmaceuticals (TCON)markets.businessinsider.com - March 13 at 7:55 PMBuy Rating for TRACON Pharmaceuticals on Strong Financials and Promising Clinical Trialsmarkets.businessinsider.com - March 8 at 1:58 AMTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - March 7 at 3:12 PMTRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 7 at 10:12 AMTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 7 at 10:12 AMTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Updateglobenewswire.com - March 5 at 4:02 PMTracon Q4 2023 Earnings Previewmsn.com - March 4 at 6:46 PMA Preview Of TRACON Pharma's Earningsbenzinga.com - March 4 at 1:41 PMTRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024globenewswire.com - February 28 at 4:02 PMTRACON Pharmaceuticals, Inc. (TCON)finance.yahoo.com - February 13 at 7:14 AMTRACON Pharma Stock (NASDAQ:TCON), Guidance and Forecastbenzinga.com - December 23 at 8:22 AMBuy Rating for TRACON Pharmaceuticals on Envafolimab’s Promising Trial Outcomes and Strong Market Potentialmarkets.businessinsider.com - December 21 at 12:02 AMTCON TRACON Pharmaceuticals, Inc.seekingalpha.com - November 25 at 5:51 PMWhy Is Tracon Pharmaceuticals (TCON) Stock Up 19% Today?msn.com - November 21 at 8:04 AMAnalysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON), Anavex Life Sciences (AVXL) and Genmab (GMAB)markets.businessinsider.com - November 21 at 1:04 AMTRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Paymentfinance.yahoo.com - November 20 at 10:02 AMPromising Financial and Clinical Prospects Bolster Buy Rating for TRACON Pharmaceuticalsmarkets.businessinsider.com - November 15 at 6:51 AMTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 12 at 1:27 PMTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - November 10 at 9:16 AMTRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 9 at 7:25 PMTRACON Pharmaceuticals (TCON) Price Target Increased by 21.88% to 6.63msn.com - November 1 at 3:27 PMTRACON Pharmaceuticals Inc TCONmorningstar.com - November 1 at 10:27 AMTRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023finance.yahoo.com - October 31 at 6:02 PMWhy Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarketbenzinga.com - October 27 at 8:32 AMTRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Plannedfinance.yahoo.com - September 18 at 10:06 AM7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Polefinance.yahoo.com - September 2 at 1:25 AMJonesTrading Downgrades TRACON Pharmaceuticals (TCON)msn.com - August 22 at 4:28 PMTCON Aug 2023 2.500 callfinance.yahoo.com - August 18 at 4:14 PMTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - August 16 at 4:34 AMQ2 2023 TRACON Pharmaceuticals Inc Earnings Callfinance.yahoo.com - August 15 at 6:34 PMTRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 14 at 4:35 PMTRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023finance.yahoo.com - August 3 at 10:42 AMTRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharmafinance.yahoo.com - July 11 at 8:48 AMWhat's Going On With TRACON Pharmaceuticals Shares Todaymsn.com - June 20 at 12:58 PMTRACON Pharmaceuticals Announces Positive Results Based on Ongoing Double-Digit Objective Response Rate for Single Agent Envafolimab in the ENVASARC Phase 2 Pivotal Trialfinance.yahoo.com - June 20 at 12:58 PMTRACON Pharmaceuticals to Present at the Maxim Group Healthcare Virtual Conferencefinance.yahoo.com - June 16 at 8:30 AMTRACON Pharmaceuticals Announces Enforcement Action to Collect Binding Arbitration Award from I-Mab Biopharmafinance.yahoo.com - June 15 at 12:29 PMTRACON Pharmaceuticals Announces Poster Presentations for Envafolimab and TRC102 at the 2023 ASCO Annual Meetingfinance.yahoo.com - May 30 at 10:06 AM Get TRACON Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent dollar warning (Ad)Your 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today. Find out for free here. TCON Media Mentions By Week TCON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TCON News Sentiment▼0.500.33▲Average Medical News Sentiment TCON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TCON Articles This Week▼11▲TCON Articles Average Week Get TRACON Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Finch Therapeutics Group News Today Kiromic BioPharma News Today Avalon GloboCare News Today Eloxx Pharmaceuticals News Today Palisade Bio News Today Gamida Cell News Today Fresh Tracks Therapeutics News Today Creative Medical Technology News Today Titan Pharmaceuticals News Today SQZ Biotechnologies News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TCON) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.